Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 34

1.

Drug-eluting stents versus bare-metal stents for off-label indications: a propensity score-matched outcome study.

Austin D, Oldroyd KG, McConnachie A, Slack R, Eteiba H, Flapan AD, Jennings KP, Northcote RJ, Pell AC, Starkey IR, Pell JP.

Circ Cardiovasc Interv. 2008 Aug;1(1):45-52. doi: 10.1161/CIRCINTERVENTIONS.108.769042.

2.

Comparison of the impact of short (<1 year) and long-term (> or =1 year) clopidogrel use following percutaneous coronary intervention on mortality.

Banerjee S, Varghese C, Samuel J, Weideman RA, Little BB, Kelly KC, Rao SV, Reilly RF, Brilakis ES.

Am J Cardiol. 2008 Nov 1;102(9):1159-62. doi: 10.1016/j.amjcard.2008.06.058. Epub 2008 Sep 11.

PMID:
18940284
3.

Outcomes after percutaneous coronary intervention in contemporary Australian practice: insights from a large multicentre registry.

Ajani AE, Reid CM, Duffy SJ, Andrianopoulos N, Lefkovits J, Black A, New G, Lew R, Shaw JA, Yan BP, Gurvitch R, Al-Fiadh A, Brennan AL, Clark DJ.

Med J Aust. 2008 Oct 20;189(8):423-8.

PMID:
18928433
4.

Long-term impact of drug-eluting stents versus bare-metal stents on all-cause mortality.

Shishehbor MH, Goel SS, Kapadia SR, Bhatt DL, Kelly P, Raymond RE, Galla JM, Brener SJ, Whitlow PL, Ellis SG.

J Am Coll Cardiol. 2008 Sep 23;52(13):1041-8. doi: 10.1016/j.jacc.2008.06.030.

5.

Long-term clinical outcomes following coronary stenting.

Anstrom KJ, Kong DF, Shaw LK, Califf RM, Kramer JM, Peterson ED, Rao SV, Matchar DB, Mark DB, Harrington RA, Eisenstein EL.

Arch Intern Med. 2008 Aug 11;168(15):1647-55. doi: 10.1001/archinte.168.15.1647.

PMID:
18695078
6.

Outcomes following coronary stenting in the era of bare-metal vs the era of drug-eluting stents.

Malenka DJ, Kaplan AV, Lucas FL, Sharp SM, Skinner JS.

JAMA. 2008 Jun 25;299(24):2868-76. doi: 10.1001/jama.299.24.2868.

7.

Drug-eluting compared with bare-metal coronary stents among elderly patients.

Groeneveld PW, Matta MA, Greenhut AP, Yang F.

J Am Coll Cardiol. 2008 May 27;51(21):2017-24. doi: 10.1016/j.jacc.2008.01.057.

8.

Comparison of coronary artery stenting outcomes in the eras before and after the introduction of drug-eluting stents.

Hannan EL, Racz M, Holmes DR, Walford G, Sharma S, Katz S, Jones RH, King SB 3rd.

Circulation. 2008 Apr 22;117(16):2071-8. doi: 10.1161/CIRCULATIONAHA.107.725531. Epub 2008 Apr 7.

9.

Balancing efficacy and safety of drug-eluting stents in patients undergoing percutaneous coronary intervention.

Jeremias A, Kirtane A.

Ann Intern Med. 2008 Feb 5;148(3):234-8. Epub 2007 Dec 17. Review.

PMID:
18087049
10.

Effectiveness and safety of drug-eluting stents in Ontario.

Tu JV, Bowen J, Chiu M, Ko DT, Austin PC, He Y, Hopkins R, Tarride JE, Blackhouse G, Lazzam C, Cohen EA, Goeree R.

N Engl J Med. 2007 Oct 4;357(14):1393-402.

11.

A meta-analysis of 16 randomized trials of sirolimus-eluting stents versus paclitaxel-eluting stents in patients with coronary artery disease.

Schömig A, Dibra A, Windecker S, Mehilli J, Suárez de Lezo J, Kaiser C, Park SJ, Goy JJ, Lee JH, Di Lorenzo E, Wu J, Jüni P, Pfisterer ME, Meier B, Kastrati A.

J Am Coll Cardiol. 2007 Oct 2;50(14):1373-80. Epub 2007 Aug 21. Review.

12.

Outcomes associated with drug-eluting and bare-metal stents: a collaborative network meta-analysis.

Stettler C, Wandel S, Allemann S, Kastrati A, Morice MC, Schömig A, Pfisterer ME, Stone GW, Leon MB, de Lezo JS, Goy JJ, Park SJ, Sabaté M, Suttorp MJ, Kelbaek H, Spaulding C, Menichelli M, Vermeersch P, Dirksen MT, Cervinka P, Petronio AS, Nordmann AJ, Diem P, Meier B, Zwahlen M, Reichenbach S, Trelle S, Windecker S, Jüni P.

Lancet. 2007 Sep 15;370(9591):937-48. Review.

PMID:
17869634
13.

Stent thrombosis, myocardial infarction, and death after drug-eluting and bare-metal stent coronary interventions.

Jensen LO, Maeng M, Kaltoft A, Thayssen P, Hansen HH, Bottcher M, Lassen JF, Krussel LR, Rasmussen K, Hansen KN, Pedersen L, Johnsen SP, Soerensen HT, Thuesen L.

J Am Coll Cardiol. 2007 Jul 31;50(5):463-70. Epub 2007 Jun 29. Review.

14.

Long-term safety and efficacy of drug-eluting stents: two-year results of the REAL (REgistro AngiopLastiche dell'Emilia Romagna) multicenter registry.

Marzocchi A, Saia F, Piovaccari G, Manari A, Aurier E, Benassi A, Cremonesi A, Percoco G, Varani E, Magnavacchi P, Guastaroba P, Grilli R, Maresta A.

Circulation. 2007 Jun 26;115(25):3181-8. Epub 2007 Jun 11.

15.

Patients with prior myocardial infarction, stroke, or symptomatic peripheral arterial disease in the CHARISMA trial.

Bhatt DL, Flather MD, Hacke W, Berger PB, Black HR, Boden WE, Cacoub P, Cohen EA, Creager MA, Easton JD, Hamm CW, Hankey GJ, Johnston SC, Mak KH, Mas JL, Montalescot G, Pearson TA, Steg PG, Steinhubl SR, Weber MA, Fabry-Ribaudo L, Hu T, Topol EJ, Fox KA; CHARISMA Investigators.

J Am Coll Cardiol. 2007 May 15;49(19):1982-8. Epub 2007 Apr 11.

16.

Comparison of three-year clinical outcome of sirolimus- and paclitaxel-eluting stents versus bare metal stents in patients with ST-segment elevation myocardial infarction (from the RESEARCH and T-SEARCH Registries).

Daemen J, Tanimoto S, García-García HM, Kukreja N, van de Sande M, Sianos G, de Jaegere PP, van Domburg RT, Serruys PW.

Am J Cardiol. 2007 Apr 15;99(8):1027-32. Epub 2007 Mar 6.

PMID:
17437722
17.

Stent thrombosis late after implantation of first-generation drug-eluting stents: a cause for concern.

Camenzind E, Steg PG, Wijns W.

Circulation. 2007 Mar 20;115(11):1440-55; discussion 1455. Epub 2007 Mar 7. Review. No abstract available.

18.

A pooled analysis of data comparing sirolimus-eluting stents with bare-metal stents.

Spaulding C, Daemen J, Boersma E, Cutlip DE, Serruys PW.

N Engl J Med. 2007 Mar 8;356(10):989-97. Epub 2007 Feb 12.

19.

Safety and efficacy of sirolimus- and paclitaxel-eluting coronary stents.

Stone GW, Moses JW, Ellis SG, Schofer J, Dawkins KD, Morice MC, Colombo A, Schampaert E, Grube E, Kirtane AJ, Cutlip DE, Fahy M, Pocock SJ, Mehran R, Leon MB.

N Engl J Med. 2007 Mar 8;356(10):998-1008. Epub 2007 Feb 12.

20.

Analysis of 14 trials comparing sirolimus-eluting stents with bare-metal stents.

Kastrati A, Mehilli J, Pache J, Kaiser C, Valgimigli M, Kelbaek H, Menichelli M, Sabaté M, Suttorp MJ, Baumgart D, Seyfarth M, Pfisterer ME, Schömig A.

N Engl J Med. 2007 Mar 8;356(10):1030-9. Epub 2007 Feb 12.

Items per page

Supplemental Content

Write to the Help Desk